Robert Calder
Robert Calder
LxAddictions24: Hepatitis C, other infectious diseases, and drug-related harms
LxAddictions24: Hepatitis C, other infectious diseases, and drug-related harms
LxAddictions24: Hepatitis C, other infectious diseases, and drug-related harms
Monday 30th September 2024
Emma Day discusses hepatitis C, HIV, overdose prevention, and more in this insightful episode of Addictions Edited.
10 minutes
Informative
Engaging
Supportive
Educational
Authentic
About this podcast
Author:
Robert Calder
Overview:
Categories:
Understanding Addiction & Recovery
Sobriety Toolkit
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Links:
Visit site
Episodes:
44 (View all)
Do you want to link to this podcast?
Get the buttons here!Emma Day on Hepatitis C, Infectious Diseases, and Drug-Related Harms
Episode Overview
- Insight into organising a conference track on infectious diseases and drug-related harms.
- Advice for first-time attendees of Lisbon Addictions.
- Discussion on the high quality and selection process of abstracts.
- Details on two major sessions focusing on harm reduction services and Hepatitis C elimination.
- Emma Day's role and mission at INHSU.
We really serve as a bridge between researchers, healthcare practitioners, and communities of people with living and lived experience of drug use.
In this episode of Addictions Edited, you'll find a fascinating conversation between Ben Scher and Emma Day from the International Network on Health and Hepatitis in Substance Users (INHSU). Emma shares her experience as a co-producer for Lisbon Addictions, providing an insider's look into the complexities of organising a conference track that covers crucial topics like hepatitis, HIV, soft tissue infections, and overdose prevention.
The episode delves into how these sessions are crafted to fit the conference's theme, ensuring they offer valuable insights from epidemiological, clinical science, social science, and treatment perspectives. Emma and Ben discuss the rigorous process of selecting abstracts, highlighting the high quality of submissions and the challenge of narrowing them down. They also offer practical advice for first-time attendees of Lisbon Addictions, emphasising the importance of planning your days to avoid feeling overwhelmed by the sheer volume of content.
The episode features two major sessions that Emma is particularly excited about. The first focuses on enhancing access to harm reduction services and includes case studies from Sweden, Spain, Moldova, and Switzerland. These case studies aim to provide practical takeaways on advocacy measures, data utilisation, and policy dialogue. The second session takes a critical look at the science, policy, and politics of Hepatitis C elimination.
Emma's passion for her work and her dedication to improving the health and well-being of people who use drugs shine through in this engaging discussion. If you're interested in the latest research and innovative models of care in the field of addiction, this episode is a must-listen.